ASTRO’s first bladder cancer guideline recommends trimodal therapy as a curative option for selected patients and defines ...

PROFESSIONAL powerlifting comes with some serious risks. Bones and joints can be broken in pursuit of incredible personal ...

AstraZeneca has reported positive Phase III VOLGA results for perioperative Imfinzi (durvalumab) plus neoadjuvant enfortumab vedotin in patients with muscle-invasive bladder cance ...

Chrysler says a fault in the steering column control module can cause a loss of electronic stability control in 8,329 2026 Ram 2500 heavy-duty pickups, and it is replacing the module to fix it. The ...

A Southington man is suing a Bristol Hospital doctor who allegedly never told him to get off the blood thinners he was on before performing a procedure on his bladder, which caused him to start ...

Detailed price information for Theralase Technologies Inc (TLTFF) from The Globe and Mail including charting and trades.

Radical cystectomy remains a major operation even at experienced centers and with robotic surgical techniques. Data from the ...

Visugromab combined with PD-1 inhibitor nivolumab demonstrated higher response rates versus nivolumab alone across primary ...

In patients with muscle-invasive bladder cancer (MIBC), treatment with neoadjuvant durvalumab and enfortumab vedotin, with or ...

The phase 3 VOLGA trial looks at perioperative durvalumab plus enfortumab vedotin, with and without tremelimumab, for muscle-invasive bladder cancer.

Perioperative treatment with durvalumab (Imfinzi) plus neoadjuvant enfortumab vedotin (EV) significantly improved event-free survival (EFS) and overall survival (OS) compared with radical cystectomy ...

AstraZeneca's IMFINZI plus enfortumab vedotin reduced disease progression/recurrence risk by 49% and mortality by 42% in muscle-invasive bladder ...